These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31836028)

  • 1. Ensuring safety of the blood supply in the United States: Donor screening, testing, emerging pathogens, and pathogen inactivation.
    Godbey EA; Thibodeaux SR
    Semin Hematol; 2019 Oct; 56(4):229-235. PubMed ID: 31836028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The History and Challenges of Blood Donor Screening in China.
    Li L; Li KY; Yan K; Ou G; Li W; Wang J; Song N; Tian L; Ji X; Chen Y; Liang X; Liu Z; Wu Y
    Transfus Med Rev; 2017 Apr; 31(2):89-93. PubMed ID: 28012709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Single-donor (apheresis) platelets and pooled whole-blood-derived platelets--significance and assessment of both blood products].
    Hitzler WE
    Clin Lab; 2014; 60(4):S1-39. PubMed ID: 24779310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-Borne Pathogens: A Canadian Blood Services Centre for Innovation Symposium.
    Walsh GM; Shih AW; Solh Z; Golder M; Schubert P; Fearon M; Sheffield WP
    Transfus Med Rev; 2016 Apr; 30(2):53-68. PubMed ID: 26962008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do we manage blood donors and recipients after a positive Zika screening result?
    Jimenez A; Shaz BH; Kessler D; Bloch EM
    Transfusion; 2017 Sep; 57(9):2077-2083. PubMed ID: 28734023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Product (Donor) Noninfectious and Infectious Testing and Modification.
    Sarker T; Katz LM; Bloch EM; Goel R
    Clin Lab Med; 2021 Dec; 41(4):579-598. PubMed ID: 34689966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases.
    Bloch EM; Busch MP; Corash LM; Dodd R; Hailu B; Kleinman S; O'Brien S; Petersen L; Stramer SL; Katz L
    Transfus Med Rev; 2023 Oct; 37(4):150769. PubMed ID: 37919210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts Toward Elimination of Infectious Agents in Blood Products.
    Jacquot C; Delaney M
    J Intensive Care Med; 2018 Oct; 33(10):543-550. PubMed ID: 29562814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial contamination of blood components: Norwegian strategies in identifying donors with higher risk of inducing septic transfusion reactions in recipients.
    Klausen SS; Hervig T; Seghatchian J; Reikvam H
    Transfus Apher Sci; 2014 Oct; 51(2):97-102. PubMed ID: 25242310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zika Virus and Patient Blood Management.
    Goodnough LT; Marques MB
    Anesth Analg; 2017 Jan; 124(1):282-289. PubMed ID: 27902502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protecting the blood supply from emerging pathogens: the role of pathogen inactivation.
    Allain JP; Bianco C; Blajchman MA; Brecher ME; Busch M; Leiby D; Lin L; Stramer S
    Transfus Med Rev; 2005 Apr; 19(2):110-26. PubMed ID: 15852240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occult hepatitis B infection and transfusion-transmission risk.
    Candotti D; Boizeau L; Laperche S
    Transfus Clin Biol; 2017 Sep; 24(3):189-195. PubMed ID: 28673499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Requirements for blood and blood components intended for transfusion or for further manufacturing use. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2015 May; 80(99):29841-906. PubMed ID: 26003966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-Transmitted Babesiosis.
    Villatoro T; Karp JK
    Arch Pathol Lab Med; 2019 Jan; 143(1):130-134. PubMed ID: 30376376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for Babesia microti in the U.S. Blood Supply.
    Moritz ED; Winton CS; Tonnetti L; Townsend RL; Berardi VP; Hewins ME; Weeks KE; Dodd RY; Stramer SL
    N Engl J Med; 2016 Dec; 375(23):2236-2245. PubMed ID: 27959685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost projections for implementation of safety interventions to prevent transfusion-transmitted Zika virus infection in the United States.
    Ellingson KD; Sapiano MRP; Haass KA; Savinkina AA; Baker ML; Henry RA; Berger JJ; Kuehnert MJ; Basavaraju SV
    Transfusion; 2017 Jun; 57 Suppl 2(Suppl 2):1625-1633. PubMed ID: 28591470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfusion-Transmitted Infections: an Update on Product Screening, Diagnostic Techniques, and the Path Ahead.
    Dean CL; Wade J; Roback JD
    J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29669792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of transfusion-transmissible infection in blood donors in Thammasat University Hospital between 2007-2012.
    Chiamchanya N
    J Med Assoc Thai; 2014 Oct; 97(10):1055-63. PubMed ID: 25632622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Donor exclusions, discarded blood and transfusion unsuited blood conserves of 2,13 million potential blood donors 1991 to 1994].
    Diekamp U; Wehrend W; Marklof E; Kamutzky K
    Beitr Infusionsther Transfusionsmed; 1996; 33():81-92. PubMed ID: 8974711
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.